Australia revises controversial PMA plans
This article was originally published in Clinica
Executive Summary
Australia's Therapeutic Goods Administration (TGA) has revised its controversial proposals to strengthen the pre-market assessment (PMA) of medical devices and improve the transparency of its decision-making process in light of concerns from the medtech industry. The proposals, now issued for further consultation, relate to mandatory application audits, transparency and third-party assessment.